Clinical Trial Update: Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a pomegranate-extract pill for preventing tumor growth in localized prostate cancer patients on active surveillance; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pomegranate-extract pill

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: PSA Level Less Than or Equal to Fifteen, PSA Level Less Than Ten | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05